Pharmaceutical News

RSS

Study reveals sponsorship bias in psychiatric drug trials

Psychiatric drugs are reported to be about 50% more effective in clinical trials funded by the drug's manufacturer than when trials of the same drug are sponsored by other groups, new research shows.

7 Oct 2024

Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes

Study found that influenza vaccination is highly effective in preventing infection and hospitalization in children, though efficacy against certain subtypes like H3N2 remains limited due to small sample sizes.

6 Oct 2024

Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise

Lithium aspartate at 10-15 mg/d is ineffective for treating cognitive dysfunction and fatigue in long COVID, but higher doses may offer potential benefits based on a small follow-up study.

3 Oct 2024

Cardiovascular risks post-COVID-19 vaccination: Key findings

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

3 Oct 2024

How Minnesota figures into the presidential politics of insulin prices

In June 2019, Lija Greenseid handed Minnesota Gov. Tim Walz an empty vial of insulin that her 13-year-old daughter had painted gold.

1 Oct 2024

COVID-19 vaccine uptake higher in people with mental illness but drops for those not on medication

Researchers examined the link between mental illness and COVID-19 vaccine uptake, finding high vaccination rates but lower uptake among unmedicated individuals with mental health conditions.

1 Oct 2024

The World Vaccine Congress returns to Barcelona, Spain

The World Vaccine Congress in Barcelona unites experts to discuss vaccine innovation, sustainability, and global preparedness in the evolving biotech landscape.

From World Vaccine Congress Europe 30 Sep 2024

Regulating iron overload: Liraglutide's potential benefits

Researchers assess the role of liraglutide in regulating iron metabolism in a mouse model of hereditary hemochromatosis.

30 Sep 2024

Health literacy gaps fuel unrealistic antibiotic expectations in primary care patients

Study reveals that over 93% of primary care patients expect antibiotics for common symptoms, especially in public clinics, with lack of education and health literacy contributing to these unrealistic expectations. Knowledge of antibiotic risks is a key factor influencing patient demand.

29 Sep 2024

UN declaration addresses antibiotic pollution and resistance

In 2007, researchers at University of Gothenburg, Sweden published the first in a series of studies showing massive pollution with antibiotics from pharmaceutical factories in India.

27 Sep 2024

TxGNN improves drug repurposing by predicting treatments for rare diseases with no approved therapies

A new model, TxGNN, revolutionizes zero-shot drug repurposing by predicting treatments for diseases with no known therapies, offering improved accuracy and trust via interpretable AI explanations.

27 Sep 2024

Concerns raised over safety and effectiveness of donanemab for Alzheimer’s treatment

The safety and effectiveness of donanemab - an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA) - is called into question in an investigation published by The BMJ today.

25 Sep 2024

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics.

25 Sep 2024

Higher doses of buprenorphine linked to lower emergency visits in opioid use disorder

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of inpatient services related to behavioral health (such as for mental health and substance use disorders) than adults receiving the recommended dose, according to an analysis funded by the National Institutes of Health (NIH).

25 Sep 2024

Chemical genetics uncovers promising anti-COVID compounds

This new article publication from Acta Pharmaceutica Sinica B, discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.

25 Sep 2024

Research uncovers mechanism of psychedelic-induced anxiety reduction

A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into how such drugs reduce anxiety, according to a new study.

24 Sep 2024

Brain connectivity changes after psilocybin treatment in body dysmorphic disorder patients

Body dysmorphic disorder (BDD) is a debilitating mental illness characterized by an obsessive preoccupation with perceived flaws in one's physical appearance.

24 Sep 2024

Lack of awareness contributes to under-reporting of adverse drug reactions

Around 75% of Australians have experienced a bad reaction to a medication, but fewer than half have reported it to a doctor or the Therapeutic Goods Administration (TGA), a new survey has found.

24 Sep 2024

Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the treatment of glioblastoma. Vortioxetine, an antidepressant, showed promising anti-glioblastoma activity, significantly reducing tumor size in preclinical trials.

24 Sep 2024

Liraglutide activates key brain circuits to trigger weight loss in obesity

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss through GLP-1 receptor activation.

23 Sep 2024

Previous
1
...
3
4
5
6
7
8
9
...
1433
Next

Pharmaceutical News

Study reveals sponsorship bias in psychiatric drug trials

Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes

Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise

Cardiovascular risks post-COVID-19 vaccination: Key findings

How Minnesota figures into the presidential politics of insulin prices

COVID-19 vaccine uptake higher in people with mental illness but drops for those not on medication

The World Vaccine Congress returns to Barcelona, Spain

Regulating iron overload: Liraglutide's potential benefits

Health literacy gaps fuel unrealistic antibiotic expectations in primary care patients

UN declaration addresses antibiotic pollution and resistance

TxGNN improves drug repurposing by predicting treatments for rare diseases with no approved therapies

Concerns raised over safety and effectiveness of donanemab for Alzheimer’s treatment

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Higher doses of buprenorphine linked to lower emergency visits in opioid use disorder

Chemical genetics uncovers promising anti-COVID compounds

Research uncovers mechanism of psychedelic-induced anxiety reduction

Brain connectivity changes after psilocybin treatment in body dysmorphic disorder patients

Lack of awareness contributes to under-reporting of adverse drug reactions

Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials

Liraglutide activates key brain circuits to trigger weight loss in obesity

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News